5 Providers should set realistic expectations, encourage lifestyle changes and address barriers such as cost and insurance hurdles
Although Tau levels were not fully restored to control baseline in Retatrutide-treated groups, the levels were notably higher compared to the STZ group, suggesting partial preservation of structural integrity
Individuals with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) were excluded from retatrutide trials
(2022) [59] comparing GLP-1RA plus SGLT2i combination therapy to GLP-1RA and SGLT2i monotherapies among 1,895 patients with T2DM enrolled in 8 RCTs, the addition of a GLP-1RA to SGLT2i treatment showed that drug discontinuation, diarrhea, injection-site-related events, nausea, vomiting and genital infections were more likely to occur in combination therapy
Patients are now coming to their doctors with a new primary goal: weight loss
Unlike earlier medications like semaglutide (Ozempic) and tirzepatide (Mounjaro), retatrutide is designed to act on multiple hormone receptors simultaneouslyincluding GLP-1, GIP, and glucagon receptors
